Tuberculosis

WHO / HTM/TB 2013.15. Executuve Summary Global Tuberculosis Report 2012. Dye, 1999, Consensus Statement, Global Burden of tuberculosis. Estimated incidence, prevale nce, and mortality by country, WHO, Gobal Suveillance and Monitoring Project JAMA, 282, 677 http://epi.minsal.cl/epi/html/AtlasInteractivos/Nacionales/AtlasTBC/atlas.html Hernandez-Pando, R ;Jeynathan M.; Mengistu, G; Aguilar D, Orozco H, Harboe M, et al. Persitence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection, Lancet 356, 2133-2138 http://dx.doi.org/10.1016/S0140-6736(00)03493-0. G, 2013, The Biology of Mycobacterium tuberculosis Infection mediterranean Jorunal of Hematology and Infectious Diseases, 5, e2013070, 10.4084/mjhid.2013.070 Fattorini, 2013, Trageting Dormant Bacilli to fight Tuberculosis, Mediterranean Jorurnal of Hematology and Infectious Disease, e20130727 Neil, 2013, Schluger Advances in the Diagnosis of Latent Tuberculosis Infection Semin Respi Crit Care Med, 34, 60 R Diel; M Loddenkemper, a Nienhaus Predictive Value of Interferon Release Assays and Tuberculin Skin testing for Progression From latent Infection to Disease State Chest, 142, (1) 63–75. Comstock, 1979, Isoniazid Profilaxis Among Alskan Eskimos. A final report of the Bethellsoniazid Studies, Am.Rew. Respi. Dis., 119, 827 Vernon, 2013, Treatment of latent Tuberculosis Infection, Semin, Respir Crit Care Med, 34, 67, 10.1055/s-0032-1333544 Performance of Xpert MTB/RIF versión G4 assay Geneva : Foundation for Innovative New Diagnostics 2011 (http://www.stoptb.org/wg/gli/assets/documents/map/findg4cartidge.pdf) Norbis, 2013, Tuberculosis: Lights and Shadows in the current diagostic landscape New Microbiologica, 36, 111 Zumla, 2013, Tuberculosis, N Engl. J Med, 388, 745, 10.1056/NEJMra1200894 Cyabyab, 2012, Current and novel approaches to vaccine development against tuberculosis, A Frontieer in Cellular Infection Microbiology, 2, 154